scai Weekly Update MultiBriefs
Subscribe
Contact Us
Media Kit

Browse Categories

Browse by Date

Search past issues
Search products and services

Submit Your Unique Cases for SCAI 2019 Help us to come together as a clinical community to review our...

source:

Patients undergoing percutaneous coronary intervention...

source: By Craig J. Beavers, PharmD, FAHA, AACC, BCPS-AQ Cardiology, CACP; and Jayant Bagai, MD, FACC, FSCAI

The use of manual aspiration thrombectomy in primary percutaneous coronary intervention for ST-segment elevation myocardial infarction has declined significantly since 2011, according to a new analysis of National Cardiovascular...

source: TCTMD

One in five patients who required emergency surgery to correct complications caused by diagnostic angiography or percutaneous coronary intervention died within 30 days, researchers reported in a single-center study from Germany....

source: Cardiovascular Business

Intracoronary administration of nicardipine seems to be highly effective in reversing spontaneous coronary slow-flow, according to a study published online Dec. 15 in the Journal of Invasive Cardiology. Hetal H. Mehta, MD, from...

source: HealthDay News via The Cardiology Advisor

Abbott announced that the Food and Drug Administration approved a closure device for the treatment of premature babies with patent ductus arteriosus who are nonresponsive to medical management. The Amplatzer Piccolo occluder is the first medical device that can be implanted...

source: Healio

RECOMMENDED:

Powered by MultiBriefs
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063

Subscribe to SCAI This Week

*Email:
*First Name:
*Last Name:
*Company:
Title:
Street Address:
City:
State / Province:
Zip / Postal Code:
Country:
Are you a member of SCAI? Yes   No
Privacy Policy
X